↓ Skip to main content

Dove Medical Press

It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
10 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
27 Mendeley
Title
It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
Published in
Therapeutics and Clinical Risk Management, December 2019
DOI 10.2147/tcrm.s221562
Pubmed ID
Authors

A Migliore, G Gigliucci, RJ Petrella, RR Bannuru, X Chevalier, E Maheu, R Raman, G Herrero-Beaumont, N Isailovic, M Matucci Cerinc

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 15%
Student > Bachelor 3 11%
Student > Ph. D. Student 3 11%
Lecturer 1 4%
Other 1 4%
Other 5 19%
Unknown 10 37%
Readers by discipline Count As %
Medicine and Dentistry 8 30%
Nursing and Health Professions 5 19%
Unspecified 1 4%
Computer Science 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 2 7%
Unknown 9 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2020.
All research outputs
#5,214,024
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#259
of 1,323 outputs
Outputs of similar age
#114,818
of 473,923 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 17 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.